跳至主要内容
临床试验/NCT07597564
NCT07597564尚未招募4 期

Dose-Response Interaction of Metoprolol and Sufentanil for Attenuating Hemodynamic Responses in Tracheal Intubation: Prospective Randomized Double-blind Study

Fujian Provincial Hospital1 个研究点 分布在 1 个国家目标入组 900 人开始时间: 2026年6月22日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
尚未招募
入组人数
900
试验地点
1
主要终点
hemodynamic stability success

研究概览

简要总结

This randomized, double-blind, controlled clinical study will evaluate the effects of different dose combinations of intravenous metoprolol and sufentanil on cardiovascular responses during oral endotracheal intubation under general anesthesia.

Endotracheal intubation may cause transient increases in heart rate and blood pressure due to sympathetic stimulation. This study aims to determine whether metoprolol, in combination with different doses of sufentanil, can improve hemodynamic stability during and after intubation.

A total of 900 adult patients aged 18 to 65 years with American Society of Anesthesiologists physical status I or II who are scheduled for elective non-cardiac surgery under general anesthesia with endotracheal intubation will be enrolled. Participants will be randomly assigned to one of 30 groups according to the combination of metoprolol dose and sufentanil dose. Metoprolol doses include 0, 0.1, 0.2, 0.3, 0.4, and 0.5 mg/kg, and sufentanil doses include 0.1, 0.2, 0.3, 0.4, and 0.5 mcg/kg.

All participants will receive standardized anesthetic induction and maintenance. Hemodynamic changes will be observed for 10 minutes after intubation. The main outcome is the success rate of hemodynamic stability within 0 to 10 minutes after intubation. Secondary outcomes include the incidence of hypotension, hypertension, bradycardia, and tachycardia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 to 65 years.
  • American Society of Anesthesiologists physical status I or II.
  • Scheduled for elective non-cardiac surgery.
  • Planned general anaesthesia with endotracheal intubation.

排除标准

  • Cardiovascular or respiratory diseases, such as uncontrolled hypertension or bronchial asthma.
  • Current use of β-blockers.
  • History of chronic drug use or alcohol abuse.
  • Hepatic or renal impairment.
  • Known allergy to any study drug.
  • Anticipated difficult airway.
  • Any other condition that may affect the conduct of the study.

研究组 & 干预措施

Metoprolol 0.4 mg/kg + Sufentanil 0.1 mcg/kg

Experimental

干预措施: Metoprolol (MET) (Drug)

Metoprolol 0.4 mg/kg + Sufentanil 0.1 mcg/kg

Experimental

干预措施: Sufentanil (Drug)

Metoprolol 0.4 mg/kg + Sufentanil 0.2 mcg/kg

Experimental

干预措施: Metoprolol (MET) (Drug)

Metoprolol 0.4 mg/kg + Sufentanil 0.2 mcg/kg

Experimental

干预措施: Sufentanil (Drug)

Metoprolol 0.3 mg/kg + Sufentanil 0.1 mcg/kg

Experimental

干预措施: Sufentanil (Drug)

Metoprolol 0.3 mg/kg + Sufentanil 0.2 mcg/kg

Experimental

干预措施: Metoprolol (MET) (Drug)

Metoprolol 0.3 mg/kg + Sufentanil 0.2 mcg/kg

Experimental

干预措施: Sufentanil (Drug)

Metoprolol 0.3 mg/kg + Sufentanil 0.5 mcg/kg

Experimental

干预措施: Sufentanil (Drug)

Metoprolol 0.5 mg/kg + Sufentanil 0.3 mcg/kg

Experimental

干预措施: Metoprolol (MET) (Drug)

Metoprolol 0 mg/kg + Sufentanil 0.5 mcg/kg

Active Comparator

干预措施: Sufentanil (Drug)

Metoprolol 0.1 mg/kg + Sufentanil 0.1 mcg/kg

Experimental

干预措施: Metoprolol (MET) (Drug)

Metoprolol 0.1 mg/kg + Sufentanil 0.1 mcg/kg

Experimental

干预措施: Sufentanil (Drug)

Metoprolol 0.1 mg/kg + Sufentanil 0.2 mcg/kg

Experimental

干预措施: Metoprolol (MET) (Drug)

Metoprolol 0.1 mg/kg + Sufentanil 0.2 mcg/kg

Experimental

干预措施: Sufentanil (Drug)

Metoprolol 0.1 mg/kg + Sufentanil 0.3 mcg/kg

Experimental

干预措施: Metoprolol (MET) (Drug)

Metoprolol 0.1 mg/kg + Sufentanil 0.3 mcg/kg

Experimental

干预措施: Sufentanil (Drug)

Metoprolol 0.1 mg/kg + Sufentanil 0.4 mcg/kg

Experimental

干预措施: Metoprolol (MET) (Drug)

Metoprolol 0.1 mg/kg + Sufentanil 0.4 mcg/kg

Experimental

干预措施: Sufentanil (Drug)

Metoprolol 0.1 mg/kg + Sufentanil 0.5 mcg/kg

Experimental

干预措施: Metoprolol (MET) (Drug)

Metoprolol 0.1 mg/kg + Sufentanil 0.5 mcg/kg

Experimental

干预措施: Sufentanil (Drug)

Metoprolol 0.2 mg/kg + Sufentanil 0.1 mcg/kg

Experimental

干预措施: Metoprolol (MET) (Drug)

Metoprolol 0.2 mg/kg + Sufentanil 0.1 mcg/kg

Experimental

干预措施: Sufentanil (Drug)

Metoprolol 0.2 mg/kg + Sufentanil 0.2 mcg/kg

Experimental

干预措施: Metoprolol (MET) (Drug)

Metoprolol 0.2 mg/kg + Sufentanil 0.2 mcg/kg

Experimental

干预措施: Sufentanil (Drug)

Metoprolol 0.2 mg/kg + Sufentanil 0.3 mcg/kg

Experimental

干预措施: Metoprolol (MET) (Drug)

Metoprolol 0.2 mg/kg + Sufentanil 0.3 mcg/kg

Experimental

干预措施: Sufentanil (Drug)

Metoprolol 0.2 mg/kg + Sufentanil 0.4 mcg/kg

Experimental

干预措施: Metoprolol (MET) (Drug)

Metoprolol 0.2 mg/kg + Sufentanil 0.4 mcg/kg

Experimental

干预措施: Sufentanil (Drug)

Metoprolol 0.2 mg/kg + Sufentanil 0.5 mcg/kg

Experimental

干预措施: Metoprolol (MET) (Drug)

Metoprolol 0.2 mg/kg + Sufentanil 0.5 mcg/kg

Experimental

干预措施: Sufentanil (Drug)

Metoprolol 0.3 mg/kg + Sufentanil 0.1 mcg/kg

Experimental

干预措施: Metoprolol (MET) (Drug)

Metoprolol 0.3 mg/kg + Sufentanil 0.3 mcg/kg

Experimental

干预措施: Metoprolol (MET) (Drug)

Metoprolol 0.3 mg/kg + Sufentanil 0.3 mcg/kg

Experimental

干预措施: Sufentanil (Drug)

Metoprolol 0.3 mg/kg + Sufentanil 0.4 mcg/kg

Experimental

干预措施: Metoprolol (MET) (Drug)

Metoprolol 0.3 mg/kg + Sufentanil 0.4 mcg/kg

Experimental

干预措施: Sufentanil (Drug)

Metoprolol 0.3 mg/kg + Sufentanil 0.5 mcg/kg

Experimental

干预措施: Metoprolol (MET) (Drug)

Metoprolol 0.4 mg/kg + Sufentanil 0.3 mcg/kg

Experimental

干预措施: Metoprolol (MET) (Drug)

Metoprolol 0.4 mg/kg + Sufentanil 0.3 mcg/kg

Experimental

干预措施: Sufentanil (Drug)

Metoprolol 0.4 mg/kg + Sufentanil 0.4 mcg/kg

Experimental

干预措施: Metoprolol (MET) (Drug)

Metoprolol 0.4 mg/kg + Sufentanil 0.4 mcg/kg

Experimental

干预措施: Sufentanil (Drug)

Metoprolol 0.4 mg/kg + Sufentanil 0.5 mcg/kg

Experimental

干预措施: Metoprolol (MET) (Drug)

Metoprolol 0.4 mg/kg + Sufentanil 0.5 mcg/kg

Experimental

干预措施: Sufentanil (Drug)

Metoprolol 0.5 mg/kg + Sufentanil 0.1 mcg/kg

Experimental

干预措施: Metoprolol (MET) (Drug)

Metoprolol 0.5 mg/kg + Sufentanil 0.1 mcg/kg

Experimental

干预措施: Sufentanil (Drug)

Metoprolol 0.5 mg/kg + Sufentanil 0.2 mcg/kg

Experimental

干预措施: Metoprolol (MET) (Drug)

Metoprolol 0.5 mg/kg + Sufentanil 0.2 mcg/kg

Experimental

干预措施: Sufentanil (Drug)

Metoprolol 0.5 mg/kg + Sufentanil 0.3 mcg/kg

Experimental

干预措施: Sufentanil (Drug)

Metoprolol 0.5 mg/kg + Sufentanil 0.4 mcg/kg

Experimental

干预措施: Metoprolol (MET) (Drug)

Metoprolol 0.5 mg/kg + Sufentanil 0.4 mcg/kg

Experimental

干预措施: Sufentanil (Drug)

Metoprolol 0.5 mg/kg + Sufentanil 0.5 mcg/kg

Experimental

干预措施: Metoprolol (MET) (Drug)

Metoprolol 0.5 mg/kg + Sufentanil 0.5 mcg/kg

Experimental

干预措施: Sufentanil (Drug)

Metoprolol 0 mg/kg + Sufentanil 0.4 mcg/kg

Active Comparator

干预措施: Sufentanil (Drug)

Metoprolol 0 mg/kg + Sufentanil 0.1 mcg/kg

Active Comparator

干预措施: Sufentanil (Drug)

Metoprolol 0 mg/kg + Sufentanil 0.2 mcg/kg

Active Comparator

干预措施: Sufentanil (Drug)

Metoprolol 0 mg/kg + Sufentanil 0.3 mcg/kg

Active Comparator

干预措施: Sufentanil (Drug)

结局指标

主要结局

hemodynamic stability success

时间窗: within 0-10 min after intubation

次要结局

  • incidence of tachycardia(within 0-10 min after intubation)
  • incidence of hypotension(within 0-10 min after intubation)
  • incidence of hypertension(within 0-10 min after intubation)
  • incidence of bradycardia(within 0-10 min after intubation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yanhua Guo

Associate Chief Physician

Fujian Provincial Hospital

研究点 (1)

Loading locations...

相似试验